Silexion shareholders approve 10M share authorized increase and warrant exercisability

Silexion Therapeutics Corp

Meeting reconvened July 20, 2026 after July 13 adjournment due to lack of quorum.
Proposal 1 (warrant exercisability) approved with 93.3% in favor (214,091 votes for, 15,293 against).
Proposal 2 (authorized share increase) approved with 89.8% in favor (205,551 for, 23,382 against).
Authorized shares increased from 5,900,000 to 15,900,000 ordinary shares (par value $0.135).
Memorandum Amendment filed with Cayman Islands Registrar on July 21, 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.